Dr. Daniel H. Solomon
Dr. Solomon is an Associate Professor of Medicine at Harvard medical School. He received his medical training at Yale School of Medicine and his residency training at Boston City Hospital and Brigham and Women’s Hospital, both in Boston. He was a fellow in Rheumatology at Brigham and Women’s Hospital and received a Masters degree in Public Health at Harvard. He served as the Director of Health Services Research in the Division of Pharmacoepidemiology at Brigham and Women’s Hospital. He was appointed Chief of the Section of Clinical Sciences in Rheumatology during 2007. Dr. Solomon is the author of over 200 original scientific articles, book chapters, and reviews. He serves on the Editorial Boards of Arthritis & Rheumatism and Arthritis Care & Research. He has been the Principal Investigator on many NIH grants, AHRQ grants, Arthritis Foundation grants, and numerous grants from industry. He Chaired the American College of Rheumatology’s Conference on Drug Safety in 2007. He currently serves on the Steering Committee of the National Action Plan for Bone Health. He serves on the Scientific Advisory Board for BRASS, a large single center RA registry. As well, he is an epidemiologic consultant to CORRONA, a national RA and Psoriatic Arthritis registry.
Dr. Solomon’s research has focused on three areas. First, he has examined the drug safety and pharmacoepidemiology of rheumatic disease treatments. He originally focused on the safety of nonsteroidal anti-inflammatory drugs with respect to cardiovascular toxicity. Subsequent work has focused on comparing non-selective and selective NSAIDs in their cardiovascular risk profile. Dr. Solomon has led other efforts examining the safety of TNF antagonists with respect to cancer, lymphoma, and infectious complications. Second, he has focused on the epidemiology of cardiovascular disease in rheumatoid arthritis. His work on the Nurses’ Health Study stands as one of the largest epidemiologic investigations of cardiovascular disease in rheumatoid arthritis. Finally, he has investigated patterns of care for osteoporosis. This led to the development and testing of several innovative improvement strategies for osteoporosis management.
Dr. Solomon has also played leadership roles in the American College of Rheumatology. He has served as Co-Chair of the Subcommittee on Classification and Response Criteria. Until recently, he served as the Chair of the Quality of Care Committee overseeing work on Guidelines, Quality Measures, Criteria Sets, and Drug Safety. In the past, he has served on several different committees of the Arthritis Foundation.
